GEODE CAPITAL MANAGEMENT, LLC - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,730,988
-49.6%
1,987,559
+1.3%
0.00%0.0%
Q2 2023$9,394,909
+1.3%
1,961,358
+19.9%
0.00%0.0%
Q1 2023$9,273,342
+104024.7%
1,635,509
+2.8%
0.00%0.0%
Q4 2022$8,906
-99.9%
1,590,395
+5.6%
0.00%0.0%
Q3 2022$9,671,000
+131.4%
1,506,494
+23.6%
0.00%0.0%
Q2 2022$4,180,000
-51.5%
1,218,748
+0.8%
0.00%0.0%
Q1 2022$8,610,000
-16.5%
1,209,317
-2.3%
0.00%0.0%
Q4 2021$10,307,000
+55.0%
1,237,362
+29.5%
0.00%0.0%
Q3 2021$6,649,000
-74.8%
955,344
-13.6%
0.00%
-75.0%
Q2 2021$26,385,000
+31.7%
1,106,322
+13.7%
0.00%
+33.3%
Q1 2021$20,034,000
-7.7%
973,044
+9.8%
0.00%
-25.0%
Q4 2020$21,707,000
-4.0%
886,045
+10.9%
0.00%0.0%
Q3 2020$22,623,000
+544.0%
799,134
+8.3%
0.00%
+300.0%
Q2 2020$3,513,000
+48.7%
738,121
+11.5%
0.00%0.0%
Q1 2020$2,362,000
-44.9%
661,718
-46.7%
0.00%
Q4 2019$4,284,000
+95.1%
1,241,870
+126.7%
0.00%
-100.0%
Q3 2019$2,196,000
+48.0%
547,862
+18.8%
0.00%
Q2 2019$1,484,000
-22.3%
461,106
+65.9%
0.00%
Q1 2019$1,909,000
-11.1%
277,957
-41.6%
0.00%
Q4 2018$2,148,000
+25.1%
475,548
+110.1%
0.00%
Q3 2018$1,717,000
-11.8%
226,298
-0.0%
0.00%
-100.0%
Q2 2018$1,946,000
+16.6%
226,397
-0.5%
0.00%0.0%
Q1 2018$1,669,000
-21.4%
227,522
+8.7%
0.00%0.0%
Q4 2017$2,123,000
-22.7%
209,395
+22.3%
0.00%0.0%
Q3 2017$2,747,000
+42.9%
171,282
+0.7%
0.00%0.0%
Q2 2017$1,922,000
+2.6%
170,095
+2.3%
0.00%0.0%
Q1 2017$1,874,000
+20.4%
166,325
+5.8%
0.00%0.0%
Q4 2016$1,556,000
-9.5%
157,265
+12.4%
0.00%0.0%
Q3 2016$1,719,000
-34.2%
139,945
+55.6%
0.00%0.0%
Q2 2016$2,612,000
+27.8%
89,929
+16.8%
0.00%0.0%
Q1 2016$2,044,000
-22.4%
76,975
+2.5%
0.00%
-50.0%
Q4 2015$2,635,000
+33.6%
75,109
+12.8%
0.00%
+100.0%
Q3 2015$1,973,00066,5820.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 12,682,876$93,092,00026.99%
ARK Investment Management 2,406,723$17,665,0000.88%
Virtus ETF Advisers LLC 76,713$563,0000.49%
Bison Wealth, LLC 33,929$249,0000.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,525$143,0000.10%
Rock Springs Capital Management LP 220,000$1,615,0000.07%
FEDERATED HERMES, INC. 1,766,681$12,968,0000.04%
Spark Investment Management LLC 79,500$583,0000.04%
A.R.T. Advisors, LLC 45,952$337,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 88,684$651,0000.01%
View complete list of SERES THERAPEUTICS INC shareholders